COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,241 Articles (22,733 medRxiv, 8,508 bioRxiv)

Most recent first Previous |  Page 1257: Articles 12561-12570  | Next

Assessment of COVID-19 intervention strategies in the Nordic countries using genomic epidemiology
Duchene, S., Featherstone, L., de Blasio, B. F., Holmes, E. C., Bohlin, J., Pettersson, J. H.- O.
10.1101/2021.09.04.21263123 — Posted: 2021-09-08
Previous COVID-19 infection and antibody levels after vaccination
Ali, H., Alahmad, B., Al-Shammari, A. A., Al-Terki, A. i., Hammad, M., Cherian, P., Alkhairi, I., Sindhu, S., Thanaraj, T. A., Mohammad, A., Alghanim, G., Devarajan, S., Ahmad, R., El-Shazly, S., Dashti, A. A., Shehab, M., Al-Sabah, S., Alkandari, A., Abubaker, J., Abu-farha, M., Al-Mulla, F.
10.1101/2021.09.04.21263121 — Posted: 2021-09-08
Perceptions towards mask use in school children during the SARS-CoV-2 pandemic: the Ciao Corona Study
Ammann, P., Ulyte, A., Haile, S. R., Puhan, M. A., Kriemler, S., Radtke, T.
10.1101/2021.09.04.21262907 — Posted: 2021-09-08
Epidemiological, clinical Characteristics and mortality of patients Infected with SARS-CoV-2 Admitted of Kinshasa University Hospital, Democratic Republic of the Congo from March 24, 2020 to January 30, 2021: Two waves, two faces?
Mandina, M., Makulo, j. r., Wumba, R., Bepouka, B., odio, j., Nkodila, A., Longokolo, M., Mayasi, N., Mangala, D., Kamwiziku, G., Longo, A. L., Mpia, G., Kokusa, Y., Keke, H., Mbula, M., Situakibanza, H., Sumaili, E., Kayembe, J. M.
10.1101/2021.09.05.21262678 — Posted: 2021-09-08
Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection
Bhuiyan, M. S., Brintz, B. J., Whitcombe, A. L., Markmann, A., Bartelt, L., Moreland, N. J., Azman, A., Leung, D.
10.1101/2021.09.06.21261175 — Posted: 2021-09-08
Landscape of SARS-CoV-2 genomic surveillance, public availability extent of genomic data, and epidemic shaped by variants: a global descriptive study
Chen, Z., Azman, A., Chen, X., Zou, J., Tian, Y., Sun, R., Xu, X., Wu, Y., Lu, W., Ge, S., Zhao, Z., Yang, J., Leung, D., Domman, D., Yu, H.
10.1101/2021.09.06.21263152 — Posted: 2021-09-08
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomized controlled trial
Bonelli, M., Mrak, D., Tobudic, S., Sieghart, D., Koblischke, M., Mandl, P., Kornek, B., Simader, E., Radner, H., Perkmann, T., Haslacher, H., Mayer, M., Hofer, P., Redlich, K., Husar-Memmer, E., Fritsch-Stork, R., Thalhammer, R., Stiasny, K., Winkler, S., Smolen, J. S., Aberle, J. H., Zeitlinger, M., Heinz, L. X., Aletaha, D.
10.1101/2021.09.05.21263125 — Posted: 2021-09-08
Entrectinib - a SARS-CoV-2 inhibitor in Human Lung Tissue (HLT) cells
Peralta-Garcia, A., Torrens-Fontanals, M., Stepniewski, T. M., Grau-Exposito, J., Perea, D., Ayinampudi, V., Waldhoer, M., Zimmermann, M., Buzon, M. J., Genesca, M., Selent, J.
10.1101/2021.09.07.459123 — Posted: 2021-09-07
SARS-CoV-2 originated from SARS-CoV-1-related Bat-CoVs through Pan-CoVs rather than from SARS-CoV-2-related Bat-CoVs
Desingu, P. A., Nagarajan, K.
10.1101/2021.09.06.459210 — Posted: 2021-09-07
Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera
Uriu, K., Kimura, I., Shirakawa, K., Takaori-Kondo, A., Nakada, T.-a., Kaneda, A., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Nakagawa, S., Sato, K.
10.1101/2021.09.06.459005 — Posted: 2021-09-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).